Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1998 1
1999 1
2000 2
2001 2
2002 1
2003 1
2004 1
2005 3
2006 1
2007 3
2008 1
2009 1
2010 3
2011 4
2012 3
2013 4
2014 5
2015 1
2016 3
2017 1
2018 2
2019 2
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

40 results
Results by year
Filters applied: . Clear all
Page 1
Immune activation by DNA damage predicts response to chemotherapy and survival in oesophageal adenocarcinoma.
Turkington RC, Knight LA, Blayney JK, Secrier M, Douglas R, Parkes EE, Sutton EK, Stevenson L, McManus D, Halliday S, McCavigan AM, Logan GE, Walker SM, Steele CJ, Perner J, Bornschein J, MacRae S, Miremadi A, McCarron E, McQuaid S, Arthur K, James JA, Eatock MM, O'Neill R, Noble F, Underwood TJ, Harkin DP, Salto-Tellez M, Fitzgerald RC, Kennedy RD; Oesophageal Cancer Clinical and Molecular Stratification (OCCAMS) Study Group. Turkington RC, et al. Among authors: Eatock MM. Gut. 2019 Nov;68(11):1918-1927. doi: 10.1136/gutjnl-2018-317624. Epub 2019 Mar 9. Gut. 2019. PMID: 30852560 Free PMC article.
Glucose transporter 1 expression as a marker of prognosis in oesophageal adenocarcinoma.
Blayney JK, Cairns L, Li G, McCabe N, Stevenson L, Peters CJ, Reid NB, Spence VJ, Chisambo C, McManus D, James J, McQuaid S, Craig S, Arthur K, McArt D, Ong CJ, Lao-Sirieix P, Hamilton P, Salto-Tellez M, Eatock M, Coleman HG, Fitzgerald RC, Kennedy RD, Turkington RC; Oesophageal Cancer Clinical and Molecular Stratification (OCCAMS) Study Group. Blayney JK, et al. Among authors: Eatock M. Oncotarget. 2018 Apr 6;9(26):18518-18528. doi: 10.18632/oncotarget.24906. eCollection 2018 Apr 6. Oncotarget. 2018. PMID: 29719622 Free PMC article.
Clinical tumor staging of adenocarcinoma of the esophagus and esophagogastric junction.
Turkington RC, Parkes E, Kennedy RD, Eatock MM, Harrison C, McCloskey P, Purcell C. Turkington RC, et al. Among authors: Eatock MM. J Clin Oncol. 2015 Mar 20;33(9):1088. doi: 10.1200/JCO.2014.59.2402. Epub 2015 Feb 2. J Clin Oncol. 2015. PMID: 25646194 No abstract available.
A systematic review of non-surgical treatments for pancreatic neuroendocrine tumours.
Valle JW, Eatock M, Clueit B, Gabriel Z, Ferdinand R, Mitchell S. Valle JW, et al. Among authors: Eatock M. Cancer Treat Rev. 2014 Apr;40(3):376-89. doi: 10.1016/j.ctrv.2013.08.007. Epub 2013 Sep 8. Cancer Treat Rev. 2014. PMID: 24296109 Free article. Review.
A phase II study of capecitabine and oxaliplatin combination chemotherapy in patients with inoperable adenocarcinoma of the gall bladder or biliary tract.
Graham JS, Boyd K, Coxon FY, Wall LR, Eatock MM, Maughan TS, Highley M, Soulis E, Harden S, B├╝tzberger-Zimmerli P, Evans TR. Graham JS, et al. Among authors: Eatock MM. BMC Res Notes. 2016 Mar 12;9:161. doi: 10.1186/s13104-015-1778-4. BMC Res Notes. 2016. PMID: 26969121 Free PMC article. Clinical Trial.
Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer.
Valle J, Wasan H, Palmer DH, Cunningham D, Anthoney A, Maraveyas A, Madhusudan S, Iveson T, Hughes S, Pereira SP, Roughton M, Bridgewater J; ABC-02 Trial Investigators. Valle J, et al. N Engl J Med. 2010 Apr 8;362(14):1273-81. doi: 10.1056/NEJMoa0908721. N Engl J Med. 2010. PMID: 20375404 Free article. Clinical Trial.
40 results
Jump to page